Karyopharm Therapeutics, Inc. KPTI 深 滬
等待開盤 03-26 09:30:00 美东时间
5.21
-0.230
-4.23%
華盛通- 最 高5.71
- 今 開5.36
- 成交量 165.50万股
- 最 低 5.095
- 昨 收 5.44
- 總市值 9557.21万
- 52周最高 10.99
- 市盈率 靜 --
- 換手率 9.02%
- 52周最低 3.56
- 委 比 72.30%
- 總股本 1834.40万
- 歷史最高 735.075
- 量 比 0.38
- 振 幅 11.31%
- 歷史最低 5.095
- 每 手 1
- 風險率 1.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
今天 11:41
BUZZ-Street View: Karyopharm's cancer drug trial results limit regulatory odds
BUZZ-Street View: Karyopharm's cancer drug trial results limit regulatory odds ** Karyopharm Therapeutics KPTI.O said on Tuesday its therapy led to significant reduction in spleen size in a late-stage study of patients with myelofibrosis, a rare blood cancer, meeting only one of its two main goals *
03-25 19:49
Karyopharm Therapeutics Falls As Pivotal Trial Hits Spleen Goal But Misses Symptom Mark
Karyopharm Therapeutics shares fall after mixed Phase 3 SENTRY data show spleen reduction gains but miss symptom endpoint.
03-25 01:20
BUZZ-U.S. STOCKS ON THE MOVE-DexCom, Ocugen, Estee Lauder
BUZZ-U.S. STOCKS ON THE MOVE-DexCom, Ocugen, Estee Lauder Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 24 (Reuters) - U.S. stock index futures pointed to a lower open on
03-24 21:10
Karyopharm Therapeutics jumps 18%, raises $30M privately
Karyopharm Therapeutics (KPTI) announced a $30M private placement specifically with RA Capital and an additional ~$44M of gross proceeds if the accompanying warrants are exercised in full. In the pr...
03-24 19:57
Karyopharm血癌药物在研究中达成两大主要目标之一
Karyopharm治疗公司（Karyopharm Therapeutics）周二宣布，其一款肿瘤治疗药物在一项针对罕见血癌患者的晚期临床试验中，使患者脾脏...
03-24 19:48
UPDATE 2-Karyopharm's drug reduces spleen size in rare blood cancer study
UPDATE 2-Karyopharm's drug reduces spleen size in rare blood cancer study Adds shares in paragraph 2, details throughout March 24 (Reuters) - Karyopharm Therapeutics KPTI.O said on Tuesday its therapy for patients with a rare blood cancer showed a reduction in spleen size in a late-stage trial, meet
03-24 19:26
Karyopharm Announces $30 Million Private Placement with RA Capital
NEWTON, Mass., March 24, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that i...
03-24 19:01
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
This Strategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts change outlook on top names, including initiations, upgrades, and downgrades. MSTR has a $175 price target and CROX has a Neutral rating.
03-10 20:50
